2.2. Eligibility criteria
This protocol is extracted from research article:
Efficacy and safety of mechanical thrombectomy for cardioembolic stroke
Medicine (Baltimore), Jan 15, 2021; DOI: 10.1097/MD.0000000000024340

Randomized controlled trials (RCTs) will be included in this systematic review regardless of publication status and language. Quasi-randomized controlled trials (QRCTs) and nonrandomized studies will be excluded.

Patients include those diagnosed with cardiogenic stroke, regardless of gender, age, nationality, or race.

In this study, there is no patient and public involvement in consideration of this protocol for a systematic review.

The treatment group is treated with mechanical thrombectomy, or mechanical thrombectomy combine with other conventional treatments. The control group were patients with cardiogenic stroke who were treated with intravenous thrombolysis or intravascular interventional therapy other than mechanical thrombectomy.

Note: The content above has been extracted from a research article, so it may not display correctly.

Please log in to submit your questions online.
Your question will be posted on the Bio-101 website. We will send your questions to the authors of this protocol and Bio-protocol community members who are experienced with this method. you will be informed using the email address associated with your Bio-protocol account.

We use cookies on this site to enhance your user experience. By using our website, you are agreeing to allow the storage of cookies on your computer.